Epoetin alfa (Epogen)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Epoetin alfa (Epogen), covering 2010-04-02 to 2018-07-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin [Phase 3]